Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.46 USD | -0.57% | +0.64% | -12.82% |
04-26 | North American Morning Briefing : Tech Still in -2- | DJ |
04-25 | JPMorgan Upgrades Doximity to Neutral Rating From Underweight, Price Target is $25 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.82% | 4.59B | |
+24.59% | 441B | |
+23.92% | 257B | |
+15.80% | 149B | |
+23.09% | 89.91B | |
+58.86% | 59.61B | |
+16.48% | 48.08B | |
+5.29% | 37.28B | |
+19.92% | 35.94B | |
+12.73% | 28.27B |
- Stock Market
- Equities
- DOCS Stock
- News Doximity, Inc.
- Doximity Fiscal Q3 Adjusted EPS, Revenue Rise; Sees Q4 Revenue Between $89 Million And $90 Million